Steward Partners Investment Advisory’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $658K | Buy |
|
|||||
|
2025
Q2 | $442K | Buy |
|
|||||
|
2025
Q1 | $287K | Buy |
|
|||||
|
2024
Q4 | $221K | Buy |
|
|||||
|
2024
Q3 | $248K | Buy |
|
|||||
|
2024
Q2 | $216K | Buy |
|
|||||
|
2024
Q1 | $107K | Buy |
|
|||||
|
2023
Q4 | $91.9K | Buy |
|
|||||
|
2023
Q3 | $74.4K | Buy |
|
|||||
|
2023
Q2 | $76.9K | Hold |
|
|||||
|
2023
Q1 | $81.1K | Sell |
|
|||||
|
2022
Q4 | $101K | Buy |
|
|||||
|
2022
Q3 | $81K | Sell |
|
|||||
|
2022
Q2 | $66K | Sell |
|
|||||
|
2022
Q1 | $76K | Sell |
|
|||||
|
2021
Q4 | $128K | Hold |
|
|||||
|
2021
Q3 | $142K | Hold |
|
|||||
|
2021
Q2 | $128K | Sell |
|
|||||
|
2021
Q1 | $462K | Buy |
|
|||||
|
2020
Q4 | $98K | Sell |
|
|||||
|
2020
Q3 | $127K | Hold |
|
|||||
|
2020
Q2 | $129K | Buy |
|
|||||
|
2020
Q1 | $92K | Sell |
|
|||||
|
2019
Q4 | $131K | Hold |
|
|||||
|
2019
Q3 | $92K | Hold |
|
|||||
|
2019
Q2 | $83K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $85K | Buy |
|
|||||
|
2018
Q2 | $86K | Sell |
|
|||||
|
2018
Q1 | $145K | Buy |
|